MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$30,520K
EPS
-$1.04
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-07-31
Benefit from income taxes
-2,553
Total revenue-Infusion Technology
93
Total revenue
917
Loss on impairment of goodwill
3,100
Total revenue-Rental Third Party
197
Total revenue-Rental Related Party
112
Total revenue-Product Revenue
515
Cost of product revenue-Infusion Technology Revenue
106
Cost of product revenue-Product Revenue
28
General and administrative
13,781
Research and development
12,823
Depreciation and amortization
288
In-process research and development expense
0
Loss from operations
-29,159
Interest income
1,996
Realized gain on available-for-sale securities
178
Unrealized (loss) gain on investment - cyclo
-5,144
Unrealized (loss) gain on convertible notes receivable, due from cyclo
-719
Interest expense
658
Other income, net
310
Loss on initial investment in day three upon acquisition
0
Realized loss on investment in equity securities
0
Realized gain on investment - cyclo
0
Unrealized gain on investment - hedge funds
0
Recovery of receivables from cornerstone
0
Loss before income taxes
-33,196
Equity in loss of day three
0
Consolidated net loss
-30,643
Net loss attributable to noncontrolling interests
-123
Net loss attributable to rafael holdings, inc
-30,520
Basic EPS
-1.04
Diluted EPS
-1.04
Basic Average Shares
29,422,221
Diluted Average Shares
29,422,221
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to rafael...
-$30,520K
Net loss
attributable to...
-$123K
Consolidated net loss
-$30,643K
Benefit from income
taxes
-$2,553K
Loss before income
taxes
-$33,196K
Interest income
$1,996K
Other income, net
$310K
Realized gain on
available-for-sale securities
$178K
Loss from operations
-$29,159K
Unrealized (loss) gain on
investment - cyclo
-$5,144K
Total revenue
$917K
Unrealized (loss) gain on
convertible notes...
-$719K
Interest expense
$658K
Total
revenue-Product Revenue
$515K
General and
administrative
$13,781K
Research and development
$12,823K
Loss on impairment of
goodwill
$3,100K
Depreciation and
amortization
$288K
Cost of product
revenue-Infusion Technology...
$106K
Cost of product
revenue-Product Revenue
$28K
Buy us a coffee
Rafael Holdings, Inc. (RFL-WT)
Rafael Holdings, Inc. (RFL-WT)